JAKAVI

Identification of Jakavi

Please sign up for a free trial to see the description of this product.

Examples of the descriptions of OTHER drugs:

Lipitor 10 mg

Apo-Irbesartan 150 mg

Crestor 20 mg

Google image searchProduct monograph

Active ingredient

ruxolitinib (ruxolitinib phosphate), 15 MG

DIN: 02388014

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 19-JUL-2012

ATC:

L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
L01EJ — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
L01EJ01 — RUXOLITINIB (ATC/DDD)

Reference brand drug: Jakavi

External Links for Jakavi

Search on Google

Jakavi side effects
Jakavi dosage
ruxolitinib side effects
ruxolitinib dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find jakavi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.